Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 23 Issue 10, October 2016

Structural elucidation of a cone snail venom insulin that binds and activates the human insulin receptor informs design of ultra-fast-acting insulin analogs for diabetes therapy. Cover image of cone snail C. geographus engulfing fish prey courtesy of B.M. Olivera, University of Utah. (p 916, News and Views p 872)

Editorial

  • Here, we announce two policy changes across Nature journals: data-availability statements in all published papers and official Worldwide Protein Data Bank (wwPDB) validation reports for peer review.

    Editorial

    Advertisement

Top of page ⤴

News & Views

  • A potent toxin present in the venom of a fish-hunting cone snail is a minimized insulin (Con-Ins G1) lacking key residues involved in the receptor binding of most insulins. New data show that Con-Ins G1 nevertheless binds potently to the human insulin receptor, owing to a rearrangement that compensates for the lack of a critical binding residue.

    • Pierre De Meyts
    News & Views
  • Methicillin resistance in the clinically important bacterium Staphylococcus aureus (MRSA) has evolved in multiple S. aureus lineages through acquisition of chromosomally integrating mobile genetic elements named SCCmec. Now Rice and colleagues show that the conserved SCCmec cch gene encodes an active DNA helicase, thus suggesting that extrachromosomal replication is part of the enigmatic SCCmec horizontal-transfer mechanism.

    • Joshua P Ramsay
    News & Views
Top of page ⤴

Article

Top of page ⤴

Search

Quick links